Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer (Q46101701)
Jump to navigation
Jump to search
scientific article published on 4 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer |
scientific article published on 4 March 2009 |
Statements
1 reference
Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer (English)
1 reference
Joanna M Brell
1 reference
Khalid Matin
1 reference
Terry Evans
1 reference
Robert L Volkin
1 reference
Gauri J Kiefer
1 reference
James J Schlesselman
1 reference
Shelley Dranko
1 reference
Linda Rath
1 reference
Amy Schmotzer
1 reference
Diana Lenzner
1 reference
Ramesh K Ramanathan
1 reference
4 March 2009
1 reference
1 reference
76
1 reference
4
1 reference
270-274
1 reference
Identifiers
1 reference